|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 29 August 2007
doi: 10.1242/dev.007906
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Division of Developmental Genetics, MRC National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, UK.
* Author for correspondence (e-mail: krizzot{at}nimr.mrc.ac.uk)
Accepted 17 July 2007
 |
SUMMARY |
|---|
 TOP SUMMARY INTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Key words: SOX HMG box factor, Conditional gene deletion, Craniofacial development, Pharyngeal segmentation, Mouse
|
INTRODUCTION |
|---|
|
TOPSUMMARYINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
). In
humans, craniofacial dysmorphologies are common, ranging from simple facial
disfigurement to conductive deafness, thyroid deficiency and more complex
syndromes, such as DiGeorge (Wurdak et
al., 2006). In the mouse, ncc originating from the hindbrain begin to populate the PA at 8 days post-coitum (dpc). The cells stemming from rhombomeres (r) 1 and 2, then 4, and finally 6 and 7, migrate to the first, second and posterior PA respectively, where they surround mesodermal cells located at their core. A layer of ectoderm is present externally, whereas the internal surface of the arches is lined by endoderm. As morphogenesis takes place, ncc form skeletal and connective tissues. Mesodermal cells give rise to the muscles and endothelial cells of the arch arteries. The epidermis and sensory neurons of the epibranchial ganglia derive from the ectoderm, while the epithelium lining the pharynx and the pharyngeal endocrine glands (thymus, thyroid and parathyroids) develop from the endoderm.
The neural crest was thought to be the tissue mostly responsible for
patterning the pharyngeal arches, but it has been shown that they still
develop and are properly regionalised in its absence
(Gavalas et al., 2001;
Veitch et al., 1999). It is
now clear that the endoderm is another important source of information for the
formation of this region (Graham et al.,
2004; Graham and Smith,
2001).
Development of the pharyngeal pouches (PP), a characteristic of all
chordates, is the first physical manifestation of pharyngeal segmentation. By
physically individualising each arch they also define their anteroposterior
polarity. The PP initially develop at specific sites where the endoderm forms
an outpocketing and engages in direct contact with overlying ectoderm; they
then open and gradually elongate along the proximodistal axis of the arches
(Quinlan et al., 2004). They
are surrounded by a newly formed epithelium, the pouch margin. In mouse,
Fgf8 interacts genetically with Tbx1, implicated in DiGeorge
syndrome (Jerome and Papaioannou,
2001), for correct pharyngeal patterning
(Arnold et al., 2006;
Vitelli et al., 2002) and a
hypomorphic mutation of Fgfr1 leads to agenesis of the proximal
domain of PA2 at the benefit of the flanking pouches
(Trokovic et al., 2003). In
Tbx1 mutant mice, fusion of the distal ganglia of the ninth (IX) and
tenth (X) cranial nerves illustrates another important function of the PP
endoderm: at early stages it induces overlying ectoderm to form the
epibranchial placodes, which give rise to the distal portion of the cranial
ganglia (Baker and Bronner-Fraser,
2001).
The X-linked gene Sox3, which encodes an HMG box protein, is
predominantly expressed throughout the developing central nervous system
(CNS), in a pattern similar to the two other members of the SoxB1
subfamily, Sox1 and Sox2
(Collignon et al., 1996;
Wood and Episkopou, 1999).
Mice deleted for Sox3 are affected by hypopituitarism
(Rizzoti et al., 2004), as are
human patients carrying SOX3 mutations
(Laumonnier et al., 2002),
reflecting the important role of the protein in the CNS. The mutant mice, and
a subset of the human patients, are also affected by craniofacial defects. We
have now uncovered the origin of the latter phenotype, and our results are
consistent with SOX3 being required within the pharyngeal epithelia for
craniofacial morphogenesis to proceed normally.
|
MATERIALS AND METHODS |
|---|
|
TOPSUMMARYINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
) and Fgfr1n7
(Trokovic et al., 2003)
alleles were maintained respectively on MF1 and ICR outbred backgrounds. All
mouse experiments used protocols approved under the UK Animal (scientific
procedures) Act.
|
) and whole-mount in situ hybridisation
(Avilion et al., 2000) were
performed as described. Probe references are available on request.
For whole-mount immunofluorescence, embryos were fixed for 2 hours in 4%
PFA on ice. Antibodies were incubated overnight at 4°C: anti-CRABPI
(Abcam) 1/250, 2H3 (Developmental Hybridoma Bank) 1/40 for neurofilament
detection, anti-N-cadherin (Zymed) 1/200, anti-GFP (Molecular Probes) 1/500,
anti-SOX2 (Chemicon) 1/500, anti-SOX3 (a gift from T. Edlund) 1/500 or
(R&D Systems) 1/300, Alexa 594- and Alexa 488-conjugated secondary
antibodies (Molecular Probes) 1/500 and HRP-conjugated anti-mouse antibody
(Jackson laboratories) 1/300. Fluorescence-stained embryos were cleared as
described (Zucker et al.,
1999). Confocal images were obtained using a Leica TCS SP
microscope and TCSNT software. Volocity software was used for 3D
reconstructions. DAB-stained embryos were cleared in glycerol for whole-mount
imaging or processed for histology.
Phalloidin-stained embryos were fixed overnight in 4% PFA, 0.2 µg/ml TRITC-conjugated phalloidin (Sigma), mounted in Vectashield (Molecular Probes) and analysed by confocal microscopy.
Apoptosis detection
After CRABPI immunofluorescence on frozen sections, apoptotic cells were
detected using the ApopTag Fluorescein kit (Serologicals Corporation).
Apoptotic cells within a restricted CRABPI positive domain were counted on
three sections per embryo on both sides (n=7). Analysis of variance
was performed comparing the number of apoptotic cells on each side, and
significance was estimated using Student's t-test.
|
RESULTS |
|---|
|
TOPSUMMARYINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
gfp hemizygous XY or
homozygous XX mice (Sox3 null mutants) show variable phenotypes,
characterised by hypopituitarism and craniofacial defects. Although CNS
defects were found to be responsible for the hypopituitarism, both the nature
and the origin of the latter phenotype were not investigated
(Rizzoti et al., 2004). We
have found malformation, displacement or, in extreme cases, absence of the
pinna in 50% of hemizygous mutants (n=62). These malformations were
asymmetric, exclusively affecting the left ear in 74.2% of cases. Tooth
overgrowth due to jaw misalignment also affected 41.9% of the mutants, and
asymmetric paralysis of the vibrissae was found in 17.7%
(Fig. 1A,B).
To analyse these defects, skeletal preparations of newborn animals were
examined (Fig. 1C-H). These
revealed middle ear defects, but did not show any other obvious skeletal
abnormalities (Fig. 1C,D),
except for a reduction in ossification of facial bones in the null animals
[compare the chondrocytic Alcian Blue staining between wild type
(Fig. 1C,E,G) and Sox3
null littermates (Fig.
1D,F,H)]. As pituitary hormones influence skeletal growth
(Robson et al., 2002), it is
possible that this deficit/delay is linked to their hypopituitarism.
Defects in the middle ear and surrounding elements (styloid process and hyoid bone) were variable and highly asymmetric, with the left side predominantly affected (Fig. 1I, n=14). The styloid process was most often affected (Fig. 1E,F,I) and, less frequently, the stapes and the lesser horns of the hyoid bone. The distal part of the malleus, comprising the manubrium and the processus brevis, could also be abnormal and, in one case, was found to be missing (Fig. 1E-I and data not shown). In extreme cases the tympanic ring was reduced or absent (Fig. 1F,H); however, the retrotympanic process of the squamosal bone appeared intact.
The external and the middle ear develop from PA1 and 2
(Mallo, 2001), with ncc in the
latter giving rise to Reichert's cartilage, which forms the stapes, styloid
process, lesser horn part of the hyoid bone and the processus brevis
(O'Gorman, 2005). It has also
been hypothesised that the facial mimetic musculature could be of PA2 ncc
origin (O'Gorman, 2005), which
could explain the impairment of vibrissae mobility seen in some mutants. As
the elements most significantly affected in Sox3 null animals were
directly derived from PA2 ncc or consistent with a PA2 defect, we focused on
PA2 development.
|
). Therefore, the defect could arise subsequently to this
initial migration phase, just after the 10-somite stage (ss). Alternatively,
ncc migration could be disrupted from its earliest phases, but only partially.
We therefore performed CRABPI immunofluorescence during the early phase of ncc
migration, between 10 and 12 ss. On the right side of a mutant embryo, the
first ncc had reached PA2, whereas on the left side many of the crest cells
were already disrupted in their migration
(Fig. 2A,B). Therefore, the ncc
defect is present from the earliest stages and the residual staining seen in
PA2 shows that entry into the arch is only partially disrupted. This
experiment also showed that ncc migration in the first PA is unaffected.
|
|
). In mutant embryos, the proximal region of PA2 did not
show any staining, whereas the reduced distal part of the arch still expressed
Dlx2 (Fig. 2G,H). This
is consistent with the abnormal morphology of this region at 9.5 dpc and shows
that post-migratory ncc and mesenchyme are largely absent from the proximal
part of PA2. We also examined pharyngeal arch arteries (PAA) at 9.5 dpc as
they originate from ncc and mesenchyme. We found that PAA2 was missing in
phenotypically affected mutants (Fig.
2I,J). Analysis at 10.5 dpc did not reveal defects in more
posterior PAA (data not shown, n=15).
Neural crest cells accumulating at 9.5 dpc die by apoptosis in Sox3 mutants
A plausible explanation for the absence of Dlx2 staining in
proximal PA2 and of PAA2 is that the ncc die. We therefore performed TUNEL
assays on 9.5 dpc sections, coupled with CRABPI immunofluorescence, taking
advantage of the asymmetric nature of the defect by selecting mutant embryos
affected exclusively on the left. We then compared the cell death pattern on
both sides of the same embryo using the unaffected right side as control
(Fig. 2K-O). The average number
of TUNEL-positive cells on the left was almost double that of the right
(Fig. 2K). Therefore, in
Sox3 null embryos, ncc disrupted in their migration toward PA2 die by
apoptosis at 9.5 dpc.
|
To directly examine any role for SOX3 in ncc precursors, Wnt1-Cre
was used to delete Sox3 specifically in these cells
(Danielian et al., 1998). We
did not observe any PA2 defects, either in
Sox3Y/flox.gfp;
Wnt1-Cre embryos at 9.5 dpc (n=6) or adults (n=14)
(data not shown). It is therefore very unlikely that the lack of SOX3 in the
CNS, including ncc precursors, is responsible for the phenotype.
SOX3 is also expressed in the pharyngeal region, the formation of which relies in particular on the endoderm. As the latter induces the epibranchial placodes from which the distal cranial ganglia derive, we examined their development in the Sox3 null mutants, in order to highlight any potential pharyngeal defects.
SOX3 is necessary for cranial nerve and epibranchial placode formation
We first examined the cranial nerves in mutants by anti-neurofilament
immunochemistry at 10.5 dpc (Fig.
4A-C,H). In a third of the embryos (n=13), where PA2
defects were clearly apparent, nerves from the distal VII ganglia did not
reach the arch. This could be explained by the nearly complete physical
separation of the arch (Fig. 4C
inset). Some of these embryos displayed similar defects at the level of IX
ganglia, with nerves failing to reach PA3
(Fig. 4C). This arch could be
affected in a similar way to PA2, although with less penetrance, explaining
the nerve defect. We also observed fusion of nerves IX and X, complete in one
case (Fig. 4B) but less severe
in a further 30%.
|
In conclusion, as the VII ganglia innervate the face, defects affecting the growth of these nerves in Sox3 mutants could explain the vibrissae paralysis in a subset of animals. Furthermore, the defects in the epibranchial placodes suggest that the pharyngeal region is affected. We therefore examined SOX3 expression in the PA.
|
). At
8/9 ss the rostral limit of SOX3 expression was the PA2 domain, both in the
ectoderm covering the future arch and in the endoderm, albeit laterally
restricted in the latter (Fig.
5A-C). At this stage, SOX2
(Fig. 5D) was expressed more
widely than SOX3, being present in a continuous domain of head and pharyngeal
ectoderm and generally in the endoderm. When PP1 was fully formed (20/25
somites), SOX3 expression was further restricted to its posterior margin and
the flanking ectoderm and endoderm covering the anterior half of PA2
(Fig. 5E-G). SOX2 was expressed
more widely throughout the pharyngeal endoderm
(Fig. 5H), whereas in the
ectoderm its expression was stronger distally (compare
Fig. 5H, proximal, with
Fig. 5L, more distal). Levels
of expression between right and left sides were compared for both genes by
quantitative RT-PCR on right and left pharyngeal explants at 9.5 dpc. No
significant difference was observed (n=4 embryos, no difference for
Sox3, P=1, no difference for Sox2, P=0.3).
SOX3 is required for maintenance/identity of proximal PA2
Pouch morphology was then examined in 9.5 dpc Sox3 null embryos
using anti-GFP immunofluorescence. In PA2, the hypomorphic proximal region
showed continuous GFP staining (Fig.
5I,K). An abnormal mass of GFP-positive cells was visible in
rostral PA2 (Fig. 5K, inset).
SOX2 staining highlighted PA2 defects and also suggested that the
SOX3-negative, GFP-positive cells had retained their ectodermal and endodermal
epithelial identities as SOX2 and GFP colocalised. These results also
suggested that the proximal part of PA2 had been dramatically reduced at the
benefit of an enlarged pouch margin. This is the epithelium delineating the
pouches that forms as a result of a localised apposition of pharyngeal
ectoderm and endoderm. The continuous or ectopic formation of such a structure
in the proximal region of PA2 would result in narrowing and a physical
disruption of ncc migration. In order to test this hypothesis, we looked first
at the expression of markers of this compartment at 9.5 dpc.
Pax1 and Bmp7 are normally expressed in the PP margins, in the endoderm and both epithelia, respectively (Fig. 6A,C,G,E). In mutants, the narrowed proximal second arch showed continuous staining of both markers, between PP1 and PP2 (Fig. 6B,D,F,H). The defects were even more apparent in coronal sections (Fig. 6D, arrow, Fig. 6H).
Fgf3, like SOX3, was expressed in both the endoderm and ectoderm in posterior pouch margins (Fig. 6M), while Fgf8 was present in the anterior pouch margin, again in both layers (Fig. 6I,K). In Sox3 null embryos, however, both genes were expressed across the proximal PA2, suggesting that the polarity of this domain is also affected (Fig. 6J,L,N).
Bmp4 is present in the ectoderm of the cleft region of PA1 and 2 (Fig. 6O). In Sox3 null embryos, an uninterrupted Bmp4-positive region expanded across the two first PP (Fig. 6P). This extended the results observed with the endodermal markers to PA2 proximal ectoderm.
These results support the notion that the proximal region of PA2 is replaced by, or re-specified as, an aberrant pouch margin. Moreover, the anteroposterior polarity of this domain has been lost. This marker analysis also revealed morphological defects in the proximal region of PA3 (arrows, Fig. 6B), with less penetrance than those affecting PA2. PA1 was not affected, however, which is consistent with the rostral limit of SOX3 expression in presumptive PA2 (Fig. 5A,D). Finally, we examined PP3 endoderm by performing CasR in situ hybridisation and did not observe any significant anomaly even in severely PA2-affected mutants (data not shown, n=10), suggesting that the defects were restricted to the region encompassing PP1 and 2. Moreover, histological examination of the parathyroid/thymus primordia at 11.5 dpc did not reveal any significant defect in the mutants (data not shown).
Proximal PA2 morphology is abnormal without SOX3
Pharyngeal pouch elongation in chick relies on a network of actin fibres
localised apically within the pouch endoderm
(Quinlan et al., 2004). We
therefore examined this network to analyse in more detail endodermal margin
cells as the pouches formed. In wild-type embryos, apical accumulation of
actin was easily visible in pouch margins using phalloidin staining, as
initially reported in chick (Fig.
7A-C,G). In severely affected Sox3 null embryos, this
staining highlighted the PA2 phenotype: the actin network was organised as if
an uninterrupted pouch margin was present on the proximal side, connecting PP1
and 2. However, sections taken deeper in the arch revealed the presence of a
`stem' connecting the distal arch (Fig.
7E, arrow, F,H,I). Double CRABPI/phalloidin staining showed that
this stem is the route by which a reduced stream of ncc enter the arch
(Fig. 6F). At high
magnification deeper within the stem, two margins flank what could be a
residual proximal PA2, but actin polarisation is clearly disrupted
(Fig. 7H,I).
We then examined the distribution of N-cadherin associated with these actin
cables (Quinlan et al., 2004)
(Fig. 7J,L). At high
magnification, there is a clear apical accumulation in the pouch margin of
wild-type embryos (Fig. 7K),
but this was not seen in Sox3 null embryos, where instead it was
homogeneously distributed within the abnormal margin cells
(Fig. 7M).
In conclusion, in Sox3 null embryos, endodermal and ectodermal cells seem to be organised in a margin, but they do not retain their morphological characteristics, namely apical actin accumulation associated with N-cadherin; they form an enlarged but abnormal epithelium at the detriment of the proximal region of the arch, which is essentially reduced to a `stem', allowing migration of only a few ncc.
In order to understand the origin of these defects, we examined mutant embryos at 8/8.5 dpc, as SOX3 is expressed in the presumptive PA2 domain when pharyngeal segmentation takes place.
SOX3 is required early during pharyngeal segmentation
We first performed anti-GFP immunohistochemistry to examine the pharyngeal
epithelia in mutants. The morphological defect was initially seen at the time
the first pharyngeal membrane had formed (9/11 somites, data not shown) and
appeared as a prolonged region of contact in the rostrocaudal axis between the
ectoderm and the endoderm, interrupting PA2. On the embryo shown in
Fig. 7N, clearly separated
ectoderm and endoderm, corresponding to the proximal region of PA2, through
which ncc are known to migrate, were seen in only two consecutive sections on
one side but eight on the other, and the proximal region of the arch was
reduced to closely apposed/intermingled layers of ectodermal and endodermal
GFP-positive cells. This prolonged contact zone between these two layers is
likely to prefigure the formation of the enlarged pouch margin and explains
the reduction of the PA2 domain. To discriminate between an endodermal and/or
ectodermal origin of the Sox3 null phenotype, further conditional
deletions will be necessary. We tested the Tbx1Cre driver
(Brown et al., 2004), but this
is expressed in the head mesenchyme at 8.5 dpc, not in the epithelia, which
explains why we did not observe any PA2 defect. The Foxg1Cre driver
(Hebert and McConnell, 2000),
expressed in the pharyngeal endoderm, was also tested, but gave rise to
ectopic activity on our genetic background.
As SOX3 is involved in proliferation of neuroepithelial progenitors in the
ventral diencephalon (Rizzoti et al.,
2004), we looked at this and cell death in the endoderm of PA2 at
8.5 and 9.5 dpc. No differences were found between wild-type and mutant
embryos (data not shown), which is consistent with SOX3 being required for
cell fate or morphology.
Sox3 genetically interacts with Sox2 and Fgfr1 during PA2 development
Because SOX2 is expressed in the pharyngeal region, in a partially
overlapping pattern with SOX3 (Fig.
5), we looked for a genetic interaction. Animals heterozygous for
a Sox2 null mutation do not present any craniofacial defects
[homozygotes die around implantation
(Avilion et al., 2003)].
Sox3 heterozygotes only very rarely present defects, while in
hemizygotes these vary in severity. We therefore examined the effects of
removing one copy of Sox2 in Sox3 heterozygous and
hemizygous mutants. As Sox2+/-; Sox3+/- animals
have a reduced viability and Sox2+/-; Sox3Y/-
die in utero (K.R., unpublished) we examined ncc migration in mutant embryos
by CRABPI in situ hybridisation at 9.5 dpc. Removing one copy of
Sox2 increased both the penetrance and severity of the defects, with
the majority of Sox2+/-; Sox3Y/- embryos being
affected symmetrically (Table
1). This genetic interaction is likely to represent functional
redundancy between the closely related proteins encoded by the two genes.
|
; Trokovic et al.,
2005). We therefore explored genetic interactions with this gene
in two ways. First, as with Sox3+/- mutants, heterozygotes
for a hypomorphic mutation in Fgfr1 (Fgfr1n7/+)
did not present craniofacial defects. We therefore looked at double
heterozygotes (Sox3+/-; Fgfr1n7/+).
Second, we asked if introduction of one hypomorphic Fgfr1 allele on
the Sox3 null background would increase the penetrance of the
defects. We conducted these tests postnatally, scoring external ear defects
(Table 2), and in embryos,
analysing ncc migration (Fig.
8). The penetrance of the defects was clearly increased in double
mutant animals (Table 2) and
embryos (Fig. 8). The PA2
phenotype was also more severe in Sox3 null;
Fgfr1n7/+ embryos than in Sox3 null embryos
(Fig. 8B-E). Therefore,
Sox3 and Fgfr1 interact during PA2 formation.
|
).
Because of the variable penetrance of the PA2 phenotype in our mutants, we
decided to check Spry-1 expression in Sox2+/-;
Sox3Y/- embryos, where defects are more severe and the
penetrance is close to 100% (Table
1). In situ hybridisation for Spry-1 on 7 to 11 ss double
mutant embryos did not reveal any significant downregulation of the FGF
signalling target specifically in the ectoderm
(Fig. 7O,P). We also examined
Sox3 null embryos for expression of the phosphorylated form of ERK as
a readout of FGF activity, but we were unable to detect any significant
alteration between mutants and controls at 8.5 and 9.5 dpc (data not shown).
Finally, we checked the expression of Fgf3 and Fgf15, which
are both downregulated in Fgfr1 hypomorphs, but again failed to see
any significant reduction. In conclusion, SOX3 is required for the development of the second arch, where it genetically interacts both with the closely related Sox2, probably by redundancy, and also Fgfr1, linking the activity of SOXB1 proteins in this region with FGF signalling.
|
DISCUSSION |
|---|
|
TOPSUMMARYINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
; Rizzoti et al.,
2004; Weiss et al.,
2003). Here we present evidence suggesting that the latter arise
from a requirement for SOX3 within the pharyngeal epithelia, where it is
present from early stages. In support of this hypothesis, deletion of the gene
in ncc precursors, where it is normally expressed, does not explain the
occurrence of the defects. By contrast, in the complete absence of SOX3,
pharyngeal segmentation is disrupted and, probably as a consequence,
epibranchial placode development is compromised. The proximal domain of PA2 is
predominantly affected, leading to a constriction that disrupts migration of
r4 ncc into the arch. These ncc then die by apoptosis and elements almost
exclusively derived from PA2 are incomplete or missing, resulting in
craniofacial defects. We also show that Sox3 interacts genetically
with Sox2 and Fgfr1 for PA2 formation, providing new insight
into the cascade of events underlying pharyngeal segmentation, and hence
craniofacial development.
SOX3 is required for pharyngeal segmentation
SOX3 is expressed in the pharyngeal region, extending caudally from the PA2
domain, at least from 8 ss, both in the endoderm and ectoderm. At 20/25 ss, it
becomes restricted to the newly formed first posterior pouch margin and the
flanking ectoderm and endoderm. In Sox3 null mutants, as PA2 forms
between 8 and 12 ss, we observed a prolonged region of apposition between the
ectoderm and the endoderm that reduces the proximal region of the arch.
Therefore, in the absence of SOX3, the identity/maintenance of the PA2 domain
is compromised, such that the flanking pouches invade it as they form,
consequently reducing the proximal domain to an aberrant pouch margin
(Fig. 9). This suggests that
the endoderm/ectoderm interaction underlying pouch formation in a wild-type
presumptive arch domain must be spatially restricted so that each arch will
emerge and be able to host migrating ncc. In our mutants, however, the
expanded/ectopic margin is not an entirely normal epithelium, as the
polarisation of actin and distribution of associated N-cadherin and
ß-catenin (data not shown) is disrupted. It also lacks a posterior or
anterior pouch margin identity, showing that its anteroposterior patterning is
affected. However, even in the most severe cases, proximal PA2 persists as a
`stem', allowing a few ncc to reach their destination.
|
). This may reflect a role for SOX3 during subsequent
development of this gland, in which its expression is maintained.
Variability and asymmetry of the phenotype
A general aspect of the Sox3 mutant phenotype is its variability,
both in penetrance and severity. This may be explained in part by functional
redundancy with Sox2, as suggested by the interaction between the two
genes (see also Wegner and Stolt,
2005). Double mutants for Sox2 and Sox3 might be
expected to show even more severe defects, but this requires a conditional
deletion of Sox2.
The genetic interaction of Sox3 with Sox2 and Fgfr1 led not only to increased penetrance and severity, but also to more symmetrical defects in PA2. One obvious explanation for why the left side might be more `sensitive' to the loss of SOX3 is that the protein is not expressed at the same level on both sides. We checked SOX3 expression levels by quantitative RT-PCR, but failed to observe any difference. The explanation is therefore more complex and tests of genetic interaction with known players in the establishment of left-right asymmetry will be required.
More generally this aspect of the phenotype emphasises that symmetric
development of paired structures, such as the ears, is a regulated event. Such
a feature has been observed in human patients affected by Holt-Oram syndrome,
caused by TBX5 mutations, where, with a different phenotype, the left
side is also more affected (Mori and
Bruneau, 2004). The basis for this left `sensitivity' is unknown
and the Sox3 null mutation therefore represents a good model to study
such symmetry-regulating mechanisms.
SOX3 and FGF signalling in pharyngeal arch development
Relatively few mutations show specific PA2 defects in mice. Among them,
embryos homozygous for a hypomorphic mutation in Fgfr1
(Fgfr1n7/n7) show a PA2 phenotype strikingly similar to
that described here for Sox3gfp
(Trokovic et al., 2003;
Trokovic et al., 2005). The
expression of pouch markers becomes expanded across the remaining PA2 proximal
domain in both mutants. Although Fgfr1 is widely expressed in the
pharyngeal region, Trokovic et al.
(Trokovic et al., 2005)
observed that Fgf3 and Fgf15 expression were lost
specifically in the pharyngeal ectoderm of Fgfr1n7/n7
embryos early during pharyngeal development (at 8 ss) and proposed that
defects in the ectoderm are involved in abnormal pharyngeal morphogenesis.
Embryos carrying a hypomorphic mutation in Fgf8 also display
hypoplastic pharyngeal arches in addition to several other abnormalities
(Abu-Issa et al., 2002;
Frank et al., 2002).
We were able to demonstrate a strong genetic interaction between Sox3 and Fgfr1; however, we could not find any evidence for a linear relationship between the two genes or between Sox3 and genes downstream of FGF signalling, such as Sprouty-1. This strongly suggests that SOX3 and FGF signalling act in parallel events during pharyngeal development. For example, one could be involved in identity/maintenance of the arch domain whereas the other would be more specifically required for pouch morphogenesis. As these two events are inter-dependent for PA2 morphogenesis, defects would be more severe in double mutants. Alternatively, the parallel pathways could eventually converge on a common target. Identification of genes regulated by SOXB1 factors in the pharyngeal region will further clarify their role.
|
|
ACKNOWLEDGMENTS |
|---|
|
REFERENCES |
|---|
|
TOPSUMMARYINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Abu-Issa, R., Smyth, G., Smoak, I., Yamamura, K. and Meyers, E.
N. (2002). Fgf8 is required for pharyngeal arch and
cardiovascular development in the mouse. Development
129,4613
-4625.
Arnold, J. S., Werling, U., Braunstein, E. M., Liao, J.,
Nowotschin, S., Edelmann, W., Hebert, J. M. and Morrow, B. E.
(2006). Inactivation of Tbx1 in the pharyngeal endoderm results
in 22q11DS malformations. Development
133,977
-987.
Avilion, A. A., Bell, D. M. and Lovell-Badge, R. (2000). Micro-capillary tube in situ hybridisation: a novel method for processing small individual samples. Genesis 27,76 -80.[CrossRef][Medline]
Avilion, A. A., Nicolis, S. K., Pevny, L. H., Perez, L., Vivian,
N. and Lovell-Badge, R. (2003). Multipotent cell lineages in
early mouse development depend on SOX2 function. Genes
Dev. 17,126
-140.
Baker, C. V. and Bronner-Fraser, M. (2001). Vertebrate cranial placodes I. Embryonic induction. Dev. Biol. 232,1 -61.[CrossRef][Medline]
Bowl, M. R., Nesbit, M. A., Harding, B., Levy, E., Jefferson, A., Volpi, E., Rizzoti, K., Lovell-Badge, R., Schlessinger, D., Whyte, M. P. et al. (2005). An interstitial deletion-insertion involving chromosomes 2p25.3 and Xq27.1, near SOX3, causes X-linked recessive hypoparathyroidism. J. Clin. Invest. 115,2822 -2831.[CrossRef][Medline]
Brown, C. B., Wenning, J. M., Lu, M. M., Epstein, D. J., Meyers, E. N. and Epstein, J. A. (2004). Cre-mediated excision of Fgf8 in the Tbx1 expression domain reveals a critical role for Fgf8 in cardiovascular development in the mouse. Dev. Biol. 267,190 -202.[CrossRef][Medline]
Bulfone, A., Kim, H. J., Puelles, L., Porteus, M. H., Grippo, J. F. and Rubenstein, J. L. (1993). The mouse Dlx-2 (Tes-1) gene is expressed in spatially restricted domains of the forebrain, face and limbs in midgestation mouse embryos. Mech. Dev. 40,129 -140.[CrossRef][Medline]
Collignon, J., Sockanathan, S., Hacker, A., Cohen-Tannoudji, M., Norris, D., Rastan, S., Stevanovic, M., Goodfellow, P. N. and Lovell-Badge, R. (1996). A comparison of the properties of Sox-3 with Sry and two related genes, Sox-1 and Sox-2. Development 122,509 -520.[Abstract]
Danielian, P. S., Muccino, D., Rowitch, D. H., Michael, S. K. and McMahon, A. P. (1998). Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr. Biol. 8,1323 -1326.[CrossRef][Medline]
Frank, D. U., Fotheringham, L. K., Brewer, J. A., Muglia, L. J.,
Tristani-Firouzi, M., Capecchi, M. R. and Moon, A. M. (2002).
An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome.
Development 129,4591
-4603.
Gavalas, A., Trainor, P., Ariza-McNaughton, L. and Krumlauf,
R. (2001). Synergy between Hoxa1 and Hoxb1: the relationship
between arch patterning and the generation of cranial neural crest.
Development 128,3017
-3027.
Graham, A. and Smith, A. (2001). Patterning the pharyngeal arches. BioEssays 23, 54-61.[CrossRef][Medline]
Graham, A., Begbie, J. and McGonnell, I. (2004). Significance of the cranial neural crest. Dev. Dyn. 229,5 -13.[CrossRef][Medline]
Hebert, J. M. and McConnell, S. K. (2000). Targeting of cre to the Foxg1 (BF-1) locus mediates loxP recombination in the telencephalon and other developing head structures. Dev. Biol. 222,296 -306.[CrossRef][Medline]
Jerome, L. A. and Papaioannou, V. E. (2001). DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat. Genet. 27,286 -291.[CrossRef][Medline]
Laumonnier, F., Ronce, N., Hamel, B. C., Thomas, P., Lespinasse, J., Raynaud, M., Paringaux, C., Van Bokhoven, H., Kalscheuer, V., Fryns, J. P. et al. (2002). Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency. Am. J. Hum. Genet. 71,1450 -1455.[CrossRef][Medline]
Mallo, M. (2001). Formation of the middle ear: recent progress on the developmental and molecular mechanisms. Dev. Biol. 231,410 -419.[CrossRef][Medline]
Manni, L., Nancy, J. L., Zaniolo, G. and Burighel, P. (2002). Cell reorganisation during epithelial fusion and perforation: the case of the ascidian branchial fissures. Dev. Dyn. 224,303 -313.[CrossRef][Medline]
Mori, A. D. and Bruneau, B. G. (2004). TBX5 mutations and congenital heart disease: Holt-Oram syndrome revealed. Curr. Opin. Cardiol. 19,211 -215.[CrossRef][Medline]
O'Gorman, S. (2005). Second branchial arch lineages of the middle ear of wild-type and Hoxa2 mutant mice. Dev. Dyn. 234,124 -131.[CrossRef][Medline]
Quinlan, R., Martin, P. and Graham, A. (2004).
The role of actin cables in directing the morphogenesis of the pharyngeal
pouches. Development
131,593
-599.
Raverot, G., Weiss, J., Park, S. Y., Hurley, L. and Jameson, J. L. (2005). Sox3 expression in undifferentiated spermatogonia is required for the progression of spermatogenesis. Dev. Biol. 283,215 -225.[CrossRef][Medline]
Rizzoti, K., Brunelli, S., Carmignac, D., Thomas, P. Q., Robinson, I. C. and Lovell-Badge, R. (2004). SOX3 is required during the formation of the hypothalamo-pituitary axis. Nat. Genet. 36,247 -255.[CrossRef][Medline]
Robson, H., Siebler, T., Shalet, S. M. and Williams, G. R. (2002). Interactions between GH, IGF-I, glucocorticoids, and thyroid hormones during skeletal growth. Pediatr. Res. 52,137 -147.[CrossRef][Medline]
Serbedzija, G. N., Bronner-Fraser, M. and Fraser, S. E. (1992). Vital dye analysis of cranial neural crest cell migration in the mouse embryo. Development 116,297 -307.[Medline]
Trokovic, N., Trokovic, R., Mai, P. and Partanen, J.
(2003). Fgfr1 regulates patterning of the pharyngeal region.
Genes Dev. 17,141
-153.
Trokovic, N., Trokovic, R. and Partanen, J. (2005). Fibroblast growth factor signalling and regional specification of the pharyngeal ectoderm. Int. J. Dev. Biol. 49,797 -805.[CrossRef][Medline]
Veitch, E., Begbie, J., Schilling, T. F., Smith, M. M. and Graham, A. (1999). Pharyngeal arch patterning in the absence of neural crest. Curr. Biol. 9,1481 -1484.[CrossRef][Medline]
Vitelli, F., Taddei, I., Morishima, M., Meyers, E. N., Lindsay,
E. A. and Baldini, A. (2002). A genetic link between Tbx1 and
fibroblast growth factor signaling. Development
129,4605
-4611.
Wegner, M. and Stolt, C. C. (2005). From stem cells to neurons and glia: a Soxist's view of neural development. Trends Neurosci. 28,583 -588.[CrossRef][Medline]
Weiss, J., Meeks, J. J., Hurley, L., Raverot, G., Frassetto, A.
and Jameson, J. L. (2003). Sox3 is required for gonadal
function, but not sex determination, in males and females. Mol.
Cell. Biol. 23,8084
-8091.
Wood, H. B. and Episkopou, V. (1999). Comparative expression of the mouse Sox1, Sox2 and Sox3 genes from pre-gastrulation to early somite stages. Mech. Dev. 86,197 -201.[CrossRef][Medline]
Wurdak, H., Ittner, L. M. and Sommer, L. (2006). DiGeorge syndrome and pharyngeal apparatus development. BioEssays 28,1078 -1086.[CrossRef][Medline]
Zucker, R. M., Hunter, E. S., 3rd and Rogers, J. M. (1999). Apoptosis and morphology in mouse embryos by confocal laser scanning microscopy. Methods 18,473 -480.[CrossRef][Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
